Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study.
Times cited: 32
Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: The HyperGEN study.
American Journal of Hypertension.
Times cited: 42